Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adtec Plasma Technology
Fukuyama, Hiroshima, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
Adtec Plasma Technology pioneered cold plasma for chronic wound treatment and surface decontamination. Clinical trials with the Adtec MicroPlaSter device have shown superior antibacterial efficacy and accelerated wound healing compared to standard antimicrobial therapies, with significant reduction in bacterial load and no adverse events reported[6][9].
- Therapeutic areas
- Infectious DiseasesDermatology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
Max Planck Institute
Beyond the preview
Go deeper on Adtec Plasma Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adtec Plasma Technology.